Dr. Wei Wang 王玮
Chief Physician, Lecturer
Department of Gastric Surgery, Sun Yat-sen University Cancer Center, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Gastric cancer, cardia cancer, neuroendocrine tumors, and retroperitoneal tumors. Expertise includes laparoscopic minimally invasive surgery, function-preserving surgery for early gastric cancer, and comprehensive treatment for advanced stages.
Dr. Wang holds a doctorate in oncology and serves as Chief Physician and Master’s supervisor. With 20 years of clinical experience, Dr. Wang focuses on minimally invasive gastric surgery, neuroendocrine tumors, and retroperitoneal tumors. Reported case volume includes over 1,000 neuroendocrine tumor treatments and more than 3,000 gastric cancer surgeries.
Professional roles
- Member, Gastric Cancer Professional Committee, China Anti-Cancer Association
- Member, Neuroendocrine Tumor Professional Committee, China Anti-Cancer Association
- Member, Neuroendocrine Tumor Study Group, Pancreatic Cancer Professional Committee, China Anti-Cancer Association
- Member, Neuroendocrine Tumor Branch, Chinese Society of Clinical Oncology (CSCO)
Name order: in Chinese the family name comes first (Wang Wei). Papers usually list the name as Wei Wang or Wang W.
Selected publications
219 papers on PubMed matched by name and affiliation; 26 as first or senior author since 2016. Most recent first- or senior-author papers:
- Int J Cancer, 2026 (senior author): Patterns of recurrence after curative resection and adjuvant chemotherapy in gastric and gastroesophageal junction cancer. PubMed 41636654
- Eur J Nutr, 2026 (senior author): Association between low fruit consumption and elevated lung cancer mortality: epidemiological evidence from the Global Burden of Disease Study 2021. PubMed 41848893
- Int J Surg, 2025 (first author): Multimodal radiopathomics approach for predictions of prognosis and immunotherapy response in patients with gastric cancer: a multicohort retrospective study. PubMed 40705499
- Radiol Artif Intell, 2025 (senior author): Adaptive Dual-Task Deep Learning for Automated Thyroid Cancer Triaging at Screening US. PubMed 40202416
- Immunotargets Ther, 2024 (first author): Addition of Immune Checkpoint Inhibitor Showed Better Efficacy for Infiltrative Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy and Lenvatinib: A Multicenter Retrospective Study. PubMed 39184311
- Curr Eye Res, 2024 (senior author): Myopia and Rate of Peripapillary Retinal Nerve Fiber Layer Thickness in Diabetic Patients Without Retinopathy: A 2-Year Longitudinal Study. PubMed 38647053
- J Thorac Oncol, 2023 (senior author): The Causality Between Statin Use and Reduced Mortality of Esophageal Cancer Remains Unproven. PubMed 37879770
- J Exp Clin Cancer Res, 2023 (senior author): Cancer-associated fibroblast-derived PAI-1 promotes lymphatic metastasis via the induction of EndoMT in lymphatic endothelial cells. PubMed 37415190
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion